Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 189
Selected: 0
NCT IDTitle
NCT01728259First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD
NCT00717535Studying Umbilical Cord Blood From African-American Donors
NCT00897910Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
NCT00514215Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
NCT00004024Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
NCT00002585Pyrazoloacridine in Treating Women With Metastatic Breast Cancer
NCT06501040Increasing Knowledge and Interest in Cancer Clinical Trials
NCT04282343DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer
NCT00872677Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors
NCT00066326Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
NCT01612910Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery
NCT00691015Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant
NCT07343297Ask Questions About Clinical Trials
NCT00288028Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant
NCT01420874Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)
NCT00482846Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma
NCT00559897Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT00002552Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
NCT00068653Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
NCT02372877Evaluation of the AMICUS RBCx System in Sickle Cell Patients
NCT02663622Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)
NCT00030407Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
NCT02269267The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
NCT04237584A Study Comparing ARB With Radium-223 vs ARB Therapy With Placebo and the Effect Upon Survival for mCRPC Patients
NCT00004022Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
NCT01415089Tailored Web-Based Intervention for Cancer Patients and Family Caregivers
NCT03453489AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm
NCT04397679Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
NCT00918762Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx
NCT00020722Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer
NCT00897247Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite
NCT00499694Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
NCT06439914First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy
NCT01656304Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy
NCT00369109Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
NCT00438204Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00888654Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy
NCT06420167DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
NCT01416961Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)
NCT02568449Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
NCT00005027Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
NCT01051570Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel
NCT01504711Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy
NCT06576115Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
NCT00248482Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT03183050MEND 2: Making Treatment Decisions Using Genomic Testing
NCT00030420Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT07222306Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study
NCT00243048Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer
NCT00258245Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia